Search results

...era of artemisinin-based combination therapy: an appropriate public health policy?|author=Yeka A, Achan J, D'Alessandro U, Talisuna AO|journal=Lancet Infect ...nter]] (OTC) quinine as a treatment for nocturnal leg cramps. [[Pfizer]] [[Pharmaceuticals]] had been selling the brand name Legatrin for this purpose. Doctors may st

...oolants and solvents. Polyethyleneglycols are used in perfumes, cosmetics, pharmaceuticals, [[lubricant]]s, [[paint thinner]]s and [[plasticizer]]s. Ethylene glycol e ...6|page=136|title=Weapons of mass destruction: an encyclopedia of worldwide policy, technology, and history, Volume 2|author=Eric Croddy, James J. Wirtz|isbn=

...nanotechnology|energy systems]], [[pharmaceutical technology|medicine and pharmaceuticals]], [[food production]] and nutrition, and [[information technology|informat ..."Some Limits to Global Ecophagy by Biovorous Nanoreplicators, with Public Policy Recommendations" [http://www.foresight.org/nano/Ecophagy.html] With the adv

...sold as '''Marinol''' (a registered trademark of [[Solvay (company)|Solvay Pharmaceuticals]]). Dronabinol is also marketed, sold, and distributed by PAR Pharmaceutic ...nnabinol together with [[cannabidiol]]. It is marketed in [[Canada]] by GW Pharmaceuticals, being the first cannabis-based prescription drug in the world (in modern t

...a: Tidigesic-0.2 mg (slow release)or 0.3 mg/mL injectable by Sun Pharmaceuticals;Bupregesic (0.3 mg/mL) by Neon Laboratories; Morgesic (0.3 mg/mL) ...for moderate chronic pain not responding to non-opioids, marketed by Napp Pharmaceuticals Ltd., and Mundipharma and Grunenthal respectively.

...d States.<ref>[http://pharmaceuticals.mallinckrodt.com/AddictionTreatment/ Pharmaceuticals.Mallinckrodt.com]</ref> ...ndent patient: a survey report. Substance Abuse Treatment, Prevention, and Policy 3: 10.</ref> However, there have been multiple studies verifying the abilit

...[Sverdlovsk anthrax leak]]). He has provided guidance to the intelligence, policy, national security, and medical communities and has returned to the pure bi ...n is scheduled to begin in 2008. The stated intention is that high quality pharmaceuticals will be produced and become an affordable source of therapy for millions of

Unfortunately the factory was Sudan's primary source of [[pharmaceuticals]], covering the majority of the Sudanese market. [[Werner Daum]] (Germany's [[Category:Counter-terrorism policy of the United States]]